Surgery Partners Inc (SGRY)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $3.53B
Last updated: Nov 17, 2026 at 11:06 AM ET
Surgery Partners Inc (SGRY) P/E Ratio & Valuation History
Surgery Partners (SGRY) trades at 95.7x trailing earnings and 1.0x sales. Its P/E of 95.7x is above its 5-year median of 34.1x. Its forward P/E is 666.7x. The median P/E across 10 similar companies is 23.2x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 85.6% lower over the next year. Its free cash flow yield is 5.9%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 95.7x |
| Forward P/E | 666.7x |
| Price to sales | 1.0x |
| Price to book | 2.1x |
| EV/EBITDA | 11.4x |
| Price to FCF | 17.0x |
| EV/FCF | 30.3x |
| PEG | 1.7 |
| FCF yield | 5.9% |
Historical Medians
Against its 10-year medians, its P/S is 25.0% above 0.8x and its P/B is 16.7% above 1.8x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 95.7x | 34.1x | N/A |
| P/S | 1.0x | 1.0x | 0.8x |
| P/B | 2.1x | 1.8x | 1.8x |
Valuation History
Over the 5 of the 10 year ends shown that have a P/E, its P/E ranged from 22.5x in 2024 to 214.3x in 2022.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $15.45 | 33.6x | 0.6x | 1.1x |
| 2024 | $21.17 | 22.5x | 0.9x | 1.5x |
| 2023 | $31.99 | 32.3x | 1.5x | 2.0x |
| 2022 | $27.86 | 214.3x | 1.0x | 1.4x |
| 2021 | $53.41 | N/A | 1.7x | 4.1x |
| 2020 | $29.01 | N/A | 0.8x | 2.6x |
| 2019 | $15.66 | N/A | 0.4x | 1.1x |
| 2018 | $9.79 | N/A | 0.3x | 1.2x |
| 2017 | $12.10 | N/A | 0.4x | 0.9x |
| 2016 | $15.85 | 26.0x | 0.7x | 79.0x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SGRY
What is SGRY's forward P/E ratio?
Surgery Partners has a forward P/E ratio of 666.7x.
Is SGRY stock overvalued?
GNG's valuation label for SGRY is Fairly valued. Its P/E of 95.7x compares with a median of 23.2x across 10 similar companies.
What is SGRY's price to sales ratio?
Surgery Partners has a price to sales ratio of 1.0x.
What is Surgery Partners's average P/E ratio over 5 years?
Surgery Partners's median P/E over the last 5 years is 34.1x, from 56 month-end values through Oct 2026.
What is SGRY's PEG ratio?
Surgery Partners has a PEG ratio of 1.7.
SGRY pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors